CISO Global, Inc. 8-K

What Happened

• CISO Global, Inc. (CISO) filed an 8-K reporting that Nasdaq notified the company it failed to meet the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2). The initial notice referenced a closing bid below $1.00 for 30 consecutive business days (letter dated December 30, 2025).
• On June 30, 2026, Nasdaq’s Listing Qualifications staff granted CISO an additional 180‑calendar‑day compliance period (under Rule 5810(c)(3)(A)) — extending the cure deadline to December 28, 2026. The staff found CISO met the other initial listing requirements (including market value of publicly held shares) except the bid price.

Key Details

• Initial deficiency notice: December 30, 2025 (bid price below $1.00 for 30 consecutive business days).
• First cure period expiration: June 29, 2026; Nasdaq granted a second 180‑day period ending December 28, 2026.
• To regain compliance, CISO must have a closing bid of at least $1.00 for a minimum of 10 consecutive business days during the second period, or effect a reverse stock split (if necessary) completed no later than 10 business days before the December 28, 2026 deadline.
• If CISO cannot demonstrate compliance by December 28, 2026, Nasdaq will notify the company that its common stock will be delisted; CISO may then appeal to a Nasdaq Hearings Panel. The company’s common stock remains listed and tradable on The Nasdaq Capital Market for now.

Why It Matters

• This notice signals a material listing risk: failure to regain the $1.00 minimum bid price by the extended deadline could lead to delisting proceedings.
• The company has identified a reverse stock split as a potential remedy, which would change the share count and could affect per‑share metrics and liquidity.
• For investors, the stock continues to trade on Nasdaq at present, but outcomes over the next compliance period (through December 28, 2026) — including confirmation of compliance, a reverse split, or delisting and appeal — will be important to monitor.